Stephen From

Stephen From has served as the President, Chief Executive Officer and Director of EyeGate Pharmaceuticals, Inc., since October 2005. Prior to joining EyeGate, he was the Chief Financial Officer at Centelion SAS, an independent biotechnology subsidiary of Sanofi-Aventis. Previously, Mr. From spent several years as an investment banker specializing in the biotechnology and medical-device sectors as Director in the Global Healthcare Corporate and Investment Banking Group and Head of European Life Sciences for Bank of America Securities. Mr. From holds a B.S. from the University of Western Ontario, an accounting diploma from Wilfrid Laurier University and has qualified as a chartered accountant in Ontario, Canada.